These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 37275893)
1. The complement receptor C5aR2 regulates neutrophil activation and function contributing to neutrophil-driven epidermolysis bullosa acquisita. Seiler DL; Kähler KH; Kleingarn M; Sadik CD; Bieber K; Köhl J; Ludwig RJ; Karsten CM Front Immunol; 2023; 14():1197709. PubMed ID: 37275893 [TBL] [Abstract][Full Text] [Related]
2. C5aR2 Deficiency Ameliorates Inflammation in Murine Epidermolysis Bullosa Acquisita by Regulating Fcγ Receptor Expression on Neutrophils. Seiler DL; Kleingarn M; Kähler KH; Gruner C; Schanzenbacher J; Ehlers-Jeske E; Kenno S; Sadik CD; Schmidt E; Bieber K; Köhl J; Ludwig RJ; Karsten CM J Invest Dermatol; 2022 Oct; 142(10):2715-2723.e2. PubMed ID: 35007559 [TBL] [Abstract][Full Text] [Related]
3. The critical role of C5a as an initiator of neutrophil-mediated autoimmune inflammation of the joint and skin. Sadik CD; Miyabe Y; Sezin T; Luster AD Semin Immunol; 2018 Jun; 37():21-29. PubMed ID: 29602515 [TBL] [Abstract][Full Text] [Related]
5. Absence of the C5a Receptor C5aR2 Worsens Ischemic Tissue Injury by Increasing C5aR1-Mediated Neutrophil Infiltration. Wu MCL; Lee JD; Ruitenberg MJ; Woodruff TM J Immunol; 2020 Nov; 205(10):2834-2839. PubMed ID: 33028618 [TBL] [Abstract][Full Text] [Related]
6. Fcγ Receptor IIB Controls Skin Inflammation in an Active Model of Epidermolysis Bullosa Acquisita. Kovacs B; Tillmann J; Freund LC; Nimmerjahn F; Sadik CD; Bieber K; Ludwig RJ; Karsten CM; Köhl J Front Immunol; 2019; 10():3012. PubMed ID: 31993051 [TBL] [Abstract][Full Text] [Related]
7. C5aR2 Deficiency Lessens C5aR1 Distribution and Expression in Neutrophils and Macrophages. Zhang T; Ma N; Wang J; Min X; Wei L; Li K J Immunol Res; 2024; 2024():2899154. PubMed ID: 39021433 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic effects of Fc gamma RIV inhibition are mediated by selectively blocking immune complex-induced neutrophil activation in epidermolysis bullosa acquisita. Haeger SC; Kridin K; Pieper M; Griewahn L; Nimmerjahn F; Zillikens D; König P; Ludwig RJ; Hundt JE Front Immunol; 2022; 13():938306. PubMed ID: 36311755 [TBL] [Abstract][Full Text] [Related]
9. Specific Inhibition of Complement Activation Significantly Ameliorates Autoimmune Blistering Disease in Mice. Mihai S; Hirose M; Wang Y; Thurman JM; Holers VM; Morgan BP; Köhl J; Zillikens D; Ludwig RJ; Nimmerjahn F Front Immunol; 2018; 9():535. PubMed ID: 29616034 [TBL] [Abstract][Full Text] [Related]
10. Distinct roles of the anaphylatoxin receptors C3aR, C5aR1 and C5aR2 in experimental meningococcal infections. Muenstermann M; Strobel L; Klos A; Wetsel RA; Woodruff TM; Köhl J; Johswich KO Virulence; 2019 Dec; 10(1):677-694. PubMed ID: 31274379 [TBL] [Abstract][Full Text] [Related]
12. The C5a/C5aR1 axis controls the development of experimental allergic asthma independent of LysM-expressing pulmonary immune cells. Wiese AV; Ender F; Quell KM; Antoniou K; Vollbrandt T; König P; Köhl J; Laumonnier Y PLoS One; 2017; 12(9):e0184956. PubMed ID: 28931049 [TBL] [Abstract][Full Text] [Related]
13. Critical role for complement receptor C5aR2 in the pathogenesis of renal ischemia-reperfusion injury. Poppelaars F; van Werkhoven MB; Kotimaa J; Veldhuis ZJ; Ausema A; Broeren SGM; Damman J; Hempel JC; Leuvenink HGD; Daha MR; van Son WJ; van Kooten C; van Os RP; Hillebrands JL; Seelen MA FASEB J; 2017 Jul; 31(7):3193-3204. PubMed ID: 28396344 [TBL] [Abstract][Full Text] [Related]
14. Differential expression of C5aR1 and C5aR2 in innate and adaptive immune cells located in early skin lesions of bullous pemphigoid patients. Emtenani S; Holtsche MM; Stahlkopf R; Seiler DL; Burn T; Liu H; Parker M; Yilmaz K; Dikmen HO; Lang MH; Sadik CD; Karsten CM; van Beek N; Ludwig RJ; Köhl J; Schmidt E Front Immunol; 2022; 13():942493. PubMed ID: 36466856 [TBL] [Abstract][Full Text] [Related]
15. Distinct neutrophil C5a receptor inflammatory events in cows initiated by chemoattractant C5a and lipopolysaccharide around parturition and in mid lactation. Boulougouris X; Rogiers C; Van Poucke M; De Spiegeleer B; Peelman LJ; Duchateau L; Burvenich C J Dairy Sci; 2019 Feb; 102(2):1457-1472. PubMed ID: 30594380 [TBL] [Abstract][Full Text] [Related]
16. Structure and characterization of a high affinity C5a monoclonal antibody that blocks binding to C5aR1 and C5aR2 receptors. Colley CS; Popovic B; Sridharan S; Debreczeni JE; Hargeaves D; Fung M; An LL; Edwards B; Arnold J; England E; Eghobamien L; Sivars U; Flavell L; Renshaw J; Wickson K; Warrener P; Zha J; Bonnell J; Woods R; Wilkinson T; Dobson C; Vaughan TJ MAbs; 2018 Jan; 10(1):104-117. PubMed ID: 28952876 [TBL] [Abstract][Full Text] [Related]
17. Functional heterogeneity of immune complexes in epidermolysis bullosa acquisita. Gammon WR; Briggaman RA J Invest Dermatol; 1987 Nov; 89(5):478-83. PubMed ID: 3668292 [TBL] [Abstract][Full Text] [Related]
18. The C5a/C5aR2 axis promotes renal inflammation and tissue damage. Zhang T; Wu KY; Ma N; Wei LL; Garstka M; Zhou W; Li K JCI Insight; 2020 Apr; 5(7):. PubMed ID: 32191644 [TBL] [Abstract][Full Text] [Related]
19. C5a receptors C5aR1 and C5aR2 mediate opposing pathologies in a mouse model of melanoma. Nabizadeh JA; Manthey HD; Panagides N; Steyn FJ; Lee JD; Li XX; Akhir FNM; Chen W; Boyle GM; Taylor SM; Woodruff TM; Rolfe BE FASEB J; 2019 Oct; 33(10):11060-11071. PubMed ID: 31298935 [TBL] [Abstract][Full Text] [Related]